[ad_1]

Fresenius Medical Care AG & Co. KGaA (ETR: FME) has recently received a number of price target changes and ratings updates:

  • 5/11/2022 – Fresenius Medical Care AG & Co. KGaA was given a new €75.00 ($78.95) price target on by analysts at UBS Group AG.
  • 5/10/2022 – Fresenius Medical Care AG & Co. KGaA was given a new €62.00 ($65.26) price target on by analysts at Warburg Research.
  • 5/5/2022 – Fresenius Medical Care AG & Co. KGaA was given a new €58.00 ($61.05) price target on by analysts at Deutsche Bank Rese….
  • 5/5/2022 – Fresenius Medical Care AG & Co. KGaA was given a new €61.00 ($64.21) price target on by analysts at Credit Suisse Group AG.
  • 5/5/2022 – Fresenius Medical Care AG & Co. KGaA was given a new €83.40 ($87.79) price target on by analysts at Berenberg Bank.
  • 5/4/2022 – Fresenius Medical Care AG & Co. KGaA was given a new €48.70 ($51.26) price target on by analysts at JPMorgan Chase & Co..
  • 4/29/2022 – Fresenius Medical Care AG & Co. KGaA was given a new €83.40 ($87.79) price target on by analysts at Berenberg Bank.
  • 4/27/2022 – Fresenius Medical Care AG & Co. KGaA was given a new €48.70 ($51.26) price target on by analysts at JPMorgan Chase & Co..
  • 4/26/2022 – Fresenius Medical Care AG & Co. KGaA was given a new €68.00 ($71.58) price target on by analysts at Barclays PLC.
  • 4/26/2022 – Fresenius Medical Care AG & Co. KGaA was given a new €75.00 ($78.95) price target on by analysts at UBS Group AG.
  • 3/23/2022 – Fresenius Medical Care AG & Co. KGaA was given a new €83.40 ($87.79) price target on by analysts at Berenberg Bank.
  • 3/22/2022 – Fresenius Medical Care AG & Co. KGaA was given a new €71.00 ($74.74) price target on by analysts at The Goldman Sachs Group, Inc..
  • 3/22/2022 – Fresenius Medical Care AG & Co. KGaA was given a new €58.00 ($61.05) price target on by analysts at Deutsche Bank Aktiengesellschaft.
  • 3/22/2022 – Fresenius Medical Care AG & Co. KGaA was given a new €75.00 ($78.95) price target on by analysts at UBS Group AG.
  • 3/21/2022 – Fresenius Medical Care AG & Co. KGaA was given a new €48.70 ($51.26) price target on by analysts at JPMorgan Chase & Co..
  • 3/17/2022 – Fresenius Medical Care AG & Co. KGaA was given a new €83.40 ($87.79) price target on by analysts at Berenberg Bank.
  • 3/16/2022 – Fresenius Medical Care AG & Co. KGaA was given a new €75.00 ($78.95) price target on by analysts at UBS Group AG.

Shares of ETR:FME opened at €58.60 ($61.68) on Thursday. The company has a 50 day moving average of €59.87 and a 200-day moving average of €58.49. The firm has a market cap of $17.17 billion and a P/E ratio of 17.71. Fresenius Medical Care AG & Co. KGaA has a twelve month low of €50.98 ($53.66) and a twelve month high of €71.14 ($74.88). The company has a current ratio of 1.10, a quick ratio of 0.76 and a debt-to-equity ratio of 95.29.

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Read More

Want More Great Investing Ideas?

Receive News & Ratings for Fresenius Medical Care AG & Co KGaA Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Fresenius Medical Care AG & Co KGaA and related companies with MarketBeat.com’s FREE daily email newsletter.

[ad_2]

Source link